关注
Nadia Quignot
Nadia Quignot
PhD, Certara
在 certara.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Toxicokinetic models and related tools in environmental risk assessment of chemicals
A Grech, C Brochot, JL Dorne, N Quignot, FY Bois, R Beaudouin
Science of the Total Environment 578, 1-15, 2017
1192017
Characterization of endocrine-disrupting chemicals based on hormonal balance disruption in male and female adult rats
N Quignot, M Arnaud, F Robidel, A Lecomte, M Tournier, C Cren-Olivé, ...
Reproductive Toxicology 33 (3), 339-352, 2012
862012
Investigating combined toxicity of binary mixtures in bees: Meta-analysis of laboratory tests, modelling, mechanistic basis and implications for risk assessment
E Carnesecchi, C Svendsen, S Lasagni, A Grech, N Quignot, B Amzal, ...
Environment International 133, 105256, 2019
712019
Generic physiologically-based toxicokinetic modelling for fish: Integration of environmental factors and species variability
A Grech, C Tebby, C Brochot, FY Bois, A Bado-Nilles, JL Dorne, ...
Science of the Total Environment 651, 516-531, 2019
702019
A comparison of two human cell lines and two rat gonadal cell primary cultures as in vitro screening tools for aromatase modulation
N Quignot, S Desmots, R Barouki, E Lemazurier
Toxicology in vitro 26 (1), 107-118, 2012
432012
Multi-residue analysis of free and conjugated hormones and endocrine disruptors in rat testis by QuEChERS-based extraction and LC-MS/MS
C Pouech, M Tournier, N Quignot, A Kiss, L Wiest, F Lafay, ...
Analytical and bioanalytical chemistry 402, 2777-2788, 2012
392012
A Computational Model to Predict Rat Ovarian Steroid Secretion from In Vitro Experiments with Endocrine Disruptors
N Quignot, FY Bois
PloS one 8 (1), e53891, 2013
372013
Clinical impact and room for improvement of intensity and adherence to lipid lowering therapy: five years of clinical follow-up from 164,565 post-myocardial infarction patients
F Schiele, N Quignot, A Khachatryan, G Gusto, G Villa, D Kahangire, ...
International Journal of Cardiology 332, 22-28, 2021
222021
Quantification of steroids and endocrine disrupting chemicals in rat ovaries by LC-MS/MS for reproductive toxicology assessment
N Quignot, M Tournier, C Pouech, C Cren-Olivé, R Barouki, E Lemazurier
Analytical and bioanalytical chemistry 403, 1629-1640, 2012
202012
The Yin–Yang of CYP3A4: a Bayesian meta-analysis to quantify inhibition and induction of CYP3A4 metabolism in humans and refine uncertainty factors for mixture risk assessment
N Quignot, W Wiecek, B Amzal, JL Dorne
Archives of toxicology 93 (1), 107-119, 2019
182019
Data collection on toxicokinetic and toxicodynamic interactions of chemical mixtures for human risk assessment
N Quignot, C Béchaux, B Amzal
EFSA Supporting Publications 12 (3), 711E, 2015
182015
Extrapolating in vitro results to predict human toxicity
N Quignot, J Hamon, FY Bois
In vitro toxicology systems, 531-550, 2014
182014
Modeling bioavailability to organs protected by biological barriers
N Quignot
In Silico Pharmacology 1, 1-9, 2013
182013
Effectiveness and safety of oral anticoagulants in the treatment of acute venous thromboembolism: a nationwide comparative cohort study in France
L Bertoletti, G Gusto, A Khachatryan, N Quignot, J Chaves, A Moniot, ...
Thrombosis and haemostasis 122 (08), 1384-1396, 2022
172022
Survival and treatment patterns of patients with relapsed or refractory multiple myeloma in France—a cohort study using the French National Healthcare database (SNDS)
C Touzeau, N Quignot, J Meng, H Jiang, A Khachatryan, M Singh, V Taieb, ...
Annals of Hematology 100 (7), 1825-1836, 2021
122021
A generic Bayesian hierarchical model for the meta-analysis of human population variability in kinetics and its applications in chemical risk assessment
W Wiecek, JL Dorne, N Quignot, C Bechaux, B Amzal
Computational Toxicology 12, 100106, 2019
122019
Determination of endocrine disruptors and endogenic androgens and estrogens in rat serum by high-performance liquid chromatography–tandem mass spectrometry
M Tournier, C Pouech, N Quignot, F Lafay, L Wiest, E Lemazurier, ...
Steroids 104, 252-262, 2015
122015
Data collection on combined toxicity of multiple chemicals for animal health and ecological risk assessment
N Quignot, A Grech, B Amzal
EFSA Supporting Publications 12 (7), 861E, 2015
102015
The clinical and economic burden after an osteoporosis fracture in France: a nationwide population-based study
P Fardellone, L Barnieh, N Quignot, G Gusto, DA Kahangire, G Worth, ...
Archives of Osteoporosis 16 (1), 124, 2021
62021
Inter-phenotypic differences in CYP2C9 and CYP2C19 metabolism: Bayesian meta-regression of human population variability in kinetics and application in chemical risk assessment
N Quignot, W Więcek, L Lautz, JL Dorne, B Amzal
Toxicology Letters 337, 111-120, 2021
62021
系统目前无法执行此操作,请稍后再试。
文章 1–20